WUXI XINTEGRATED
Live / Applied — Non-final action mailed (as of 19 Mar 2026)
What this means for you
Not registered yet, but its 30 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99471744
- Mark type
- Stylized text
- Filed
- 30 Oct 2025
- Attorney of record
- Justin Swindells
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals; Custom manufacturing of pharmaceuticals; Custom manufacture of pharmaceutical preparations, biomedical preparations, drug conjugates, anti-body drug conjugates, chemical reagents; Biomanufacturing for others of pharmaceuticals using biological organisms in the manufacturing process; Manufacturing services for others in the field of antibody drug conjugates and intermediates thereof
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Research and development services of new pharmaceutical products; Research and development of antibody-drug conjugates; Research and development of conjugated antibodies; Product development for others; Biomedical research services; Scientific research in the nature of conducting clinical trials for others in the field of new pharmaceutical development; Product development consulting in the field of pharmaceuticals, anti-bodies, conjugated antibodies, chemical reagents
Owner
- WuXi XDC Cayman Inc., Grand Cayman, KY
Prosecution history
- 19 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Mar 2026 — NON-FINAL ACTION E-MAILED
- 19 Mar 2026 — NON-FINAL ACTION WRITTEN
- 15 Mar 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 30 Oct 2025 — NEW APPLICATION ENTERED